|
|
Vaccine Detail
|
Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine |
| Vaccine Information |
- Vaccine Name: Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: Live, attenuated vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Antigen: GM-CSF (NCT00836407)
- Immunization Route: Intradermal injection (i.d.)
- Description: Allogeneic pancreatic tumor cells are transfected with a GM-CSF gene to treat ocally advanced, unresectable or metastatic pancreatic adenocarcinoma. It may be in combination with Ipilimumab (an antibody that blocks negative signals to T cells). (NCT00836407)
|
| Host Response |
|
|
| References |
NCT00836407: Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer [https://clinicaltrials.gov/study/NCT00836407]
|
|
